• Search MS Observer

   

• Categories

  • News
  • Personal Stories
  • Research
  • Work & Disability

• Recent Comments

  • Janel Mitchell on Two Woman Climbers with Multiple Sclerosis Near Summit of Mt Everest in Lead Up to First World MS Day
  • Gary Mullennix on MS expert downplays Italian surgeon’s treatment
  • Tee on Stem Cell Tourists Denied: Costa Rica Stops Treatments at Top Clinic
  • Multiple Sclerosis on O’Jays Singer Reveals Long Battle With Multiple Sclerosis
  • wyfinti on Chemical in Marijuana to Slow Multiple Sclerosis?

• Recent Posts

  • Hopes for reversing age-associated effects in MS patients
  • Canadian dies following MS surgery in U.S.
  • Multiple sclerosis changes Garland man’s outlook on marijuana
  • Multiple Sclerosis Changes With the Seasons
  • MS Patient, Singer Gives to Others – WSJ.com
  • Multiple sclerosis theory dealt a blow by studies – Los Angeles Times
  • Doc calls costly therapy ‘robbery’
  • Stem Cell Tourists Denied: Costa Rica Stops Treatments at Top Clinic
  • Vitamin D Linked to Poor Learning Performance in Patients With MS
  • O’Jays Singer Reveals Long Battle With Multiple Sclerosis
  • Liberation or placebo effect?
  • Twin Study Deepens Multiple Sclerosis Mystery
  • UV Radiation, Not Vitamin D, Might Limit Multiple Sclerosis Symptoms
  • Discovery May Lead to Better Multiple Sclerosis Treatments – BusinessWeek
  • Learning to Trust Myself

• Archives

  • January 2012
  • July 2011
  • October 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008

•  

   

   

   

MONDAY, March 29 (HealthDay News) — There may be two types of multiple sclerosis and each may respond differently to treatment with the first-line drug commonly prescribed for the condition, new research suggests.

Among multiple sclerosis (MS) patients who take the popular drug, known as interferon beta, overall effectiveness is only fair, with about half of all patients experiencing an average one-third reduction in recurrences, according to researchers at Stanford University.

….

In this study, which was performed in mice and human blood samples, investigators focused on two cytokines called gamma interferon and IL-17. Cytokines are chemicals used by immune cells to communicate.

The researchers found that treatment interferon beta benefited mice with MS induced by gamma-interferon-secreting T cells but worsened symptoms in mice with MS induced by IL-17-secreting T cells.

read the rest via Discovery May Lead to Better Multiple Sclerosis Treatments – BusinessWeek.

Comments

• Blogroll

  • Mayo Clinic – Multiple Sclerosis
  • National Multiple Sclerosis Society
  • This is MS
  • Wikipedia on MS

• Communities

  • Living with Multiple Sclerosis
  • MS World Forums
  • Patients Like Me

• Resources

  • Living with Multiple Sclerosis
  • MS World
  • Patients Like Me
  • Understanding Multiple Sclerosis

•  

   

   

   

•  

   

   

• Important Notice

  This site posts excerpts and summaries of articles of interest to people with multiple sclerosis and their families, along with links to the full articles in the journals in which they were published.

  I have multiple sclerosis (primary progressive), but I am neither a doctor nor a research scientist. I have no connection to the people mentioned in these articles, and have no more information about the subject of any given article than is contained in the article itself. Please do not ask me for medical advice or how to contact people mentioned in these articles. If contact information is not contained in the article itself, your best bet is to Google the name of the person, company or clinic you are seeking.